REFRACTORY SECONDARY ACUTE MYELOID LEUKEMIA

Clinical trials for REFRACTORY SECONDARY ACUTE MYELOID LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY SECONDARY ACUTE MYELOID LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY SECONDARY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New 3-Drug cocktail targets Hard-to-Treat leukemia

Disease control Recruiting now

This early-phase study tests whether adding ruxolitinib to two standard drugs (azacitidine and venetoclax) is safe and tolerable for people with acute myeloid leukemia (AML) that has returned or not responded to prior treatment. About 51 adults will receive the combination to fin…

Matched conditions: REFRACTORY SECONDARY ACUTE MYELOID LEUKEMIA

Phase: PHASE1 • Sponsor: Jennifer Saultz • Aim: Disease control

Last updated May 04, 2026 16:22 UTC

REFRACTORY SECONDARY ACUTE MYELOID LEUKEMIA

Get alerted when new REFRACTORY SECONDARY ACUTE MYELOID LEUKEMIA trials appear

New 3-Drug cocktail targets Hard-to-Treat leukemia